BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 31050922)

  • 1. Screening for Human Papillomavirus in a Low- and Middle-Income Country.
    Atkinson AE; Mandujano CAM; Bejarano S; Kennedy LS; Tsongalis GJ
    J Glob Oncol; 2019 May; 5():JGO1800233. PubMed ID: 31050922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of human papillomavirus genotype among Moroccan women during a local screening program.
    Alhamany Z; El Mzibri M; Kharbach A; Malihy A; Abouqal R; Jaddi H; Benomar A; Attaleb M; Lamalmi N; Cherradi N
    J Infect Dev Ctries; 2010 Nov; 4(11):732-9. PubMed ID: 21252451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Risk human papillomavirus genotype distribution in the Northern region of Portugal: Data from regional cervical cancer screening program.
    Sousa H; Tavares A; Campos C; Marinho-Dias J; Brito M; Medeiros R; Baldaque I; Lobo C; Leça L; Monteiro P; Tavares F; Henrique R
    Papillomavirus Res; 2019 Dec; 8():100179. PubMed ID: 31377173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand.
    Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Srisomboon J; Intaraphet S; Siriaunkgul S
    PLoS One; 2016; 11(6):e0158184. PubMed ID: 27336913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigation of human papillomavirus prevalence in women in Eskişehir, Turkey by Pap smear, hybrid capture 2 test and consensus real-time polymerase chain reaction and typing with pyrosequencing method].
    Aslan FG; Us T; Kaşifoğlu N; Özalp SS; Akgün Y; Öge T
    Mikrobiyol Bul; 2016 Jan; 50(1):73-85. PubMed ID: 27058331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of infections with human immunodeficiency virus and human papillomavirus in Honduras.
    Ferrera A; Melchers WJ; Velema JP; Figueroa M
    Am J Trop Med Hyg; 1997 Aug; 57(2):138-41. PubMed ID: 9288804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversity of human papillomavirus typing among women population living in rural and remote areas of Brazilian territory.
    Lorenzi AT; Fregnani JH; Villa LL; Sichero L; Nunes EM; Longatto-Filho A
    Papillomavirus Res; 2019 Dec; 8():100186. PubMed ID: 31539646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of human papillomavirus infection among women presenting for cervical cancer screening in Chile, 2014-2015.
    Balanda M; Quiero A; Vergara N; Espinoza G; Martín HS; Rojas G; Ramírez E
    Med Microbiol Immunol; 2016 Dec; 205(6):585-594. PubMed ID: 27539577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
    Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
    Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
    de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
    Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of human papillomavirus infection among women from quilombo communities in northeastern Brazil.
    Nascimento MDDSB; Vidal FCB; Silva MACND; Batista JE; Lacerda Barbosa MDC; Muniz Filho WE; Bezerra GFB; Castro Viana GM; Branco RCC; Brito LMO
    BMC Womens Health; 2018 Jan; 18(1):1. PubMed ID: 29291721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus screening and cervical cancer prevention.
    Sasieni PD
    J Am Med Womens Assoc (1972); 2000; 55(4):216-9. PubMed ID: 10935355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of human papillomavirus DNA in routine cervical scraping samples: use for a national cervical cancer screening program in a developing nation.
    Othman N; Othman NH
    Asian Pac J Cancer Prev; 2014; 15(5):2245-9. PubMed ID: 24716964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women.
    Blossom DB; Beigi RH; Farrell JJ; Mackay W; Qadadri B; Brown DR; Rwambuya S; Walker CJ; Kambugu FS; Abdul-Karim FW; Whalen CC; Salata RA
    J Med Virol; 2007 Jun; 79(6):758-65. PubMed ID: 17457908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of Multicolor Melt Curve Analysis for High-Risk Human Papilloma Virus Detection in Low- and Middle-Income Countries: A Pilot Study for Expanded Cervical Cancer Screening in Honduras.
    Turner SA; Deharvengt SJ; Lyons KD; Espinal JAP; LaRochelle EPM; Bejarano S; Kennedy L; Tsongalis GJ
    J Glob Oncol; 2018 Sep; 4():1-8. PubMed ID: 30241169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical high-risk human papillomavirus infection among women residing in the Gulf Cooperation Council countries: Prevalence, type-specific distribution, and correlation with cervical cytology.
    Ali MAM; Bedair RN; Abd El Atti RM
    Cancer Cytopathol; 2019 Sep; 127(9):567-577. PubMed ID: 31390155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV prevalence and genotype distribution among women in Shandong Province, China: Analysis of 94,489 HPV genotyping results from Shandong's largest independent pathology laboratory.
    Jiang L; Tian X; Peng D; Zhang L; Xie F; Bi C; Wang R; Wang J; Qi D
    PLoS One; 2019; 14(1):e0210311. PubMed ID: 30653566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burden and genotype distribution of high-risk Human Papillomavirus infection and cervical cytology abnormalities at selected obstetrics and gynecology clinics of Addis Ababa, Ethiopia.
    Ali KE; Mohammed IA; Difabachew MN; Demeke DS; Haile T; Ten Hove RJ; Kumssa TH; Woldu ZL; Haile EL; Tullu KD
    BMC Cancer; 2019 Aug; 19(1):768. PubMed ID: 31382907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rural distribution of human papilloma virus in low- and middle-income countries.
    Atkinson A; Studwell C; Bejarano S; Castellón AMZ; Espinal JAP; Deharvengt S; LaRochelle EPM; Kennedy LS; Tsongalis GJ
    Exp Mol Pathol; 2018 Apr; 104(2):146-150. PubMed ID: 29551573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.